Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Using Murine Models to Investigate Tumor-Lymphoid Interactions: Spotlight on Chronic Lymphocytic Leukemia and Angioimmunoblastic T-Cell Lymphoma.

Herek TA, Cutucache CE.

Front Oncol. 2017 May 2;7:86. doi: 10.3389/fonc.2017.00086. eCollection 2017. Review.

2.

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.

Lemonnier F, Cairns RA, Inoue S, Li WY, Dupuy A, Broutin S, Martin N, Fataccioli V, Pelletier R, Wakeham A, Snow BE, de Leval L, Pujals A, Haioun C, Paci A, Tobin ER, Narayanaswamy R, Yen K, Jin S, Gaulard P, Mak TW.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15084-15089. doi: 10.1073/pnas.1617929114. Epub 2016 Dec 12.

3.

A Case of Cutaneous Epstein-Barr Virus-Associated Diffuse Large B-Cell Lymphoma in an Angioimmunoblastic T-Cell Lymphoma.

Lee MH, Moon IJ, Lee WJ, Won CH, Chang SE, Choi JH, Lee MW.

Ann Dermatol. 2016 Dec;28(6):789-791. Epub 2016 Nov 23. No abstract available.

4.

Successful treatment of angioimmunoblastic T-cell lymphoma with clarithromycin.

Ohe M, Hashino S.

Blood Res. 2016 Jun;51(2):139-42. doi: 10.5045/br.2016.51.2.139. Epub 2016 Jun 23. No abstract available.

5.

Expression of the significance of silent information regulator type-1 in Angioimmunoblastic T-cell lymphoma is greater association with tumorigenesis and has strong implications for adverse prognosis.

Ren Y, Gu Y, Wang W, Wang J, Li X, Wang Y, Gao H, Dong X, Tian Y.

Cell Cycle. 2016 Jun 17;15(12):1545-51. doi: 10.1080/15384101.2016.1172157. Epub 2016 Apr 28.

6.
7.

IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.

Wang C, McKeithan TW, Gong Q, Zhang W, Bouska A, Rosenwald A, Gascoyne RD, Wu X, Wang J, Muhammad Z, Jiang B, Rohr J, Cannon A, Steidl C, Fu K, Li Y, Hung S, Weisenburger DD, Greiner TC, Smith L, Ott G, Rogan EG, Staudt LM, Vose J, Iqbal J, Chan WC.

Blood. 2015 Oct 8;126(15):1741-52. doi: 10.1182/blood-2015-05-644591. Epub 2015 Aug 12.

8.

Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations.

Lage LA, Cabral TC, Costa Rde O, Gonçalves Mde C, Levy D, Zerbini MC, Pereira J.

Rev Bras Hematol Hemoter. 2015 Jul-Aug;37(4):277-84. doi: 10.1016/j.bjhh.2015.03.017. Epub 2015 Jun 7.

9.

CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.

Lefèvre G, Copin MC, Roumier C, Aubert H, Avenel-Audran M, Grardel N, Poulain S, Staumont-Sallé D, Seneschal J, Salles G, Ghomari K, Terriou L, Leclech C, Morati-Hafsaoui C, Morschhauser F, Lambotte O, Ackerman F, Trauet J, Geffroy S, Dumezy F, Capron M, Roche-Lestienne C, Taieb A, Hatron PY, Dubucquoi S, Hachulla E, Prin L, Labalette M, Launay D, Preudhomme C, Kahn JE; French Eosinophil Network..

Haematologica. 2015 Aug;100(8):1086-95. doi: 10.3324/haematol.2014.118042. Epub 2015 Feb 14.

10.

Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.

Cai Q, Chen K, Young KH.

Exp Mol Med. 2015 Jan 23;47:e133. doi: 10.1038/emm.2014.105. Review.

11.

Pathophysiology of T follicular helper cells in humans and mice.

Ueno H, Banchereau J, Vinuesa CG.

Nat Immunol. 2015 Feb;16(2):142-52. doi: 10.1038/ni.3054. Review.

12.

Potential role of (18)F-2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography imaging in patients presenting with generalized lymphadenopathy.

Karunanithi S, Kumar G, Sharma P, Bal C, Kumar R.

Indian J Nucl Med. 2015 Jan-Mar;30(1):31-8. doi: 10.4103/0972-3919.147532.

13.

Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice.

Muto H, Sakata-Yanagimoto M, Nagae G, Shiozawa Y, Miyake Y, Yoshida K, Enami T, Kamada Y, Kato T, Uchida K, Nanmoku T, Obara N, Suzukawa K, Sanada M, Nakamura N, Aburatani H, Ogawa S, Chiba S.

Blood Cancer J. 2014 Dec 12;4:e264. doi: 10.1038/bcj.2014.83.

14.

Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.

Nakamoto-Matsubara R, Sakata-Yanagimoto M, Enami T, Yoshida K, Yanagimoto S, Shiozawa Y, Nanmoku T, Satomi K, Muto H, Obara N, Kato T, Kurita N, Yokoyama Y, Izutsu K, Ota Y, Sanada M, Shimizu S, Komeno T, Sato Y, Ito T, Kitabayashi I, Takeuchi K, Nakamura N, Ogawa S, Chiba S.

PLoS One. 2014 Oct 13;9(10):e109714. doi: 10.1371/journal.pone.0109714. eCollection 2014.

15.

Disease-specific mutations in mature lymphoid neoplasms: recent advances.

Sakata-Yanagimoto M, Enami T, Yokoyama Y, Chiba S.

Cancer Sci. 2014 Jun;105(6):623-9. doi: 10.1111/cas.12408. Epub 2014 May 12. Review.

16.
17.

Early lesions in lymphoid neoplasia: Conclusions based on the Workshop of the XV. Meeting of the European Association of Hematopathology and the Society of Hematopathology, in Uppsala, Sweden.

Fend F, Cabecadas J, Gaulard P, Jaffe ES, Kluin P, Kuzu I, Peterson L, Wotherspoon A, Sundström C.

J Hematop. 2012 Sep;5(3). doi: 10.1007/s12308-012-0148-6.

18.

ROQUIN/RC3H1 alterations are not found in angioimmunoblastic T-cell lymphoma.

Auguste T, Travert M, Tarte K, Amé-Thomas P, Artchounin C, Martin-Garcia N, de Reynies A, de Leval L, Gaulard P, Delfau-Larue MH.

PLoS One. 2013 Jun 25;8(6):e64536. doi: 10.1371/journal.pone.0064536. Print 2013.

19.

Pathobiology of T-cell and NK-cell lymphomas.

Bajor-Dattilo EB, Pittaluga S, Jaffe ES.

Best Pract Res Clin Haematol. 2013 Mar;26(1):75-87. doi: 10.1016/j.beha.2013.04.007. Epub 2013 May 23. Review.

20.

Cytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets.

Stachowiak R, Lyzniak M, Budziszewska BK, Roeske K, Bielecki J, Hoser G, Kawiak J.

J Biomed Biotechnol. 2012;2012:954375. doi: 10.1155/2012/954375. Epub 2012 Oct 3.

Supplemental Content

Support Center